Nuzenio

Approves Preferential Issue

Approves Preferential Issue news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Aptus Pharma approves 16.1 lakh share preferential allotment to 192 investors - scanx.tradescanx.trade · Sun, 09 Aug 2026 07:59:28 GMT Mukka Proteins shareholders approve ₹47 crore preferential warrant issue - scanx.tradescanx.trade · Sat, 08 Aug 2026 12:00:29 GMT Deccan Gold Mines approves ₹130.67 crore preferential allotment for exploration - scanx.tradescanx.trade · Fri, 07 Aug 2026 18:21:03 GMT Kabra Extrusiontechnik Board Approves ₹120 Crore Preferential Issue of 32 Lakh Shares - SahiSahi · Fri, 07 Aug 2026 09:51:02 GMT Nazara approves Rs 733.5 Cr preferential share issue; new CEO to hold 4.67% stake - EntrackrEntrackr · Thu, 06 Aug 2026 09:34:58 GMT Nazara Tech Approves ₹733-Crore Preferential Share Issue At ₹306 Per Share - SahiSahi · Thu, 06 Aug 2026 09:00:57 GMT Oriental Rail Infrastructure approves postal ballot for preferential issue fund variation - scanx.tradescanx.trade · Thu, 06 Aug 2026 07:00:00 GMT Samyak International secures BSE approval for ₹6.8 crore preferential issue - scanx.tradescanx.trade · Wed, 05 Aug 2026 14:54:52 GMT

Timeline

Sun, 09 Aug 2026 07:59:28 GMTAptus Pharma approves 16.1 lakh share preferential allotment to 192 investors - scanx.trade

Sat, 08 Aug 2026 12:00:29 GMTMukka Proteins shareholders approve ₹47 crore preferential warrant issue - scanx.trade

Fri, 07 Aug 2026 18:21:03 GMTDeccan Gold Mines approves ₹130.67 crore preferential allotment for exploration - scanx.trade

Fri, 07 Aug 2026 09:51:02 GMTKabra Extrusiontechnik Board Approves ₹120 Crore Preferential Issue of 32 Lakh Shares - Sahi

Thu, 06 Aug 2026 09:34:58 GMTNazara approves Rs 733.5 Cr preferential share issue; new CEO to hold 4.67% stake - Entrackr

Thu, 06 Aug 2026 09:00:57 GMTNazara Tech Approves ₹733-Crore Preferential Share Issue At ₹306 Per Share - Sahi

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Aptus Pharma2 live mentions Mukka Proteins2 live mentions Deccan Gold Mines2 live mentions Approves2 live mentions Crore Preferential Issue2 live mentions Sahi2 live mentions CEO2 live mentions Crore Preferential Share2 live mentions Issue At2 live mentions Oriental Rail Infrastructure2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Approves Preferential Issue.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.